Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-05 Purchase |
2024-12-09 4:09 pm |
Aileron Therapeutics Inc. | ALRN | WINDSOR JAMES BRIAN President and CEO |
400 | $2.244 | $898 | 7,508 (Indirect Direct) |
View |
2024-06-14 Sale |
2024-06-17 7:03 pm |
Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner |
6,607 | $3.2644 | $21,568 | 1,746,549 (Direct) |
View |
2024-06-10 Sale |
2024-06-12 6:18 pm |
Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner |
24,671 | $3.2714 | $80,710 | 1,753,156 (Direct) |
View |
2024-06-05 Sale |
2024-06-07 6:59 pm |
Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner |
12,315 | $3.291 | $40,528 | 1,777,827 (Direct) |
View |
2024-05-01 Sale(A) |
2024-05-14 5:54 pm |
Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner |
20,315 | $4.2074 | $85,473 | 1,790,142 (Direct) |
View |
2024-04-29 Sale |
2024-05-01 7:15 pm |
Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner |
31,151 | $4.4654 | $139,103 | 1,779,306 (Direct) |
View |
2023-12-15 Purchase |
2023-12-18 5:56 pm |
AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN President and COO |
225 | $3.37 | $758 | 5,347 (Indirect Direct) |
View |
2023-11-20 Purchase |
2023-11-21 4:43 pm |
AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN President and COO |
5,076 | $1.9675 | $9,987 | 5,122 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-12-02 Option Award |
2024-12-06 4:41 pm |
N/A 2034-12-01 |
Aileron Therapeutics Inc. | ALRN | Aivado Manuel Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-12-02 Option Award |
2024-12-06 4:38 pm |
N/A 2034-12-01 |
Aileron Therapeutics Inc. | ALRN | Ambros Reinhard J. Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-12-02 Option Award |
2024-12-06 4:35 pm |
N/A 2034-12-01 |
Aileron Therapeutics Inc. | ALRN | Fairey William Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-12-02 Option Award |
2024-12-06 4:34 pm |
N/A 2034-12-01 |
Aileron Therapeutics Inc. | ALRN | VON RICKENBACH JOSEF H Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-12-02 Option Award |
2024-12-06 4:32 pm |
N/A 2034-12-01 |
Aileron Therapeutics Inc. | ALRN | Musso Alan A Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-12-02 Option Award |
2024-12-04 4:05 pm |
N/A 2034-12-01 |
Aileron Therapeutics Inc. | ALRN | WINDSOR JAMES BRIAN President and CEO |
517,500 | $0 | 517,500 (Direct) |
View |
2024-08-20 Option Award |
2024-08-22 4:09 pm |
N/A 2034-08-19 |
Aileron Therapeutics Inc. | ALRN | Aivado Manuel Director |
2,725 | $0 | 2,725 (Direct) |
View |
2024-08-20 Option Award |
2024-08-22 4:07 pm |
N/A 2034-08-19 |
Aileron Therapeutics Inc. | ALRN | VON RICKENBACH JOSEF H Director |
2,725 | $0 | 2,725 (Direct) |
View |
2024-08-20 Option Award |
2024-08-22 4:06 pm |
N/A 2034-08-19 |
Aileron Therapeutics Inc. | ALRN | Fairey William Director |
2,725 | $0 | 2,725 (Direct) |
View |
2024-08-20 Option Award |
2024-08-22 4:06 pm |
N/A 2034-08-19 |
Aileron Therapeutics Inc. | ALRN | Ambros Reinhard J. Director |
2,725 | $0 | 2,725 (Direct) |
View |
2024-08-20 Option Award |
2024-08-22 4:05 pm |
N/A 2034-08-19 |
Aileron Therapeutics Inc. | ALRN | Musso Alan A Director |
2,725 | $0 | 2,725 (Direct) |
View |
Ownership |
2024-04-30 3:32 pm |
N/A N/A |
Aileron Therapeutics Inc. | ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner |
0 | $0 | 1,812,627 (Direct) |
View |
2024-02-28 Option Award(A) |
2024-04-10 4:15 pm |
N/A 2034-02-27 |
Aileron Therapeutics Inc. | ALRN | VON RICKENBACH JOSEF H Director |
2,725 | $0 | 2,725 (Direct) |
View |
2024-02-28 Option Award(A) |
2024-04-10 4:15 pm |
N/A 2034-02-27 |
Aileron Therapeutics Inc. | ALRN | Ambros Reinhard J. Director |
2,725 | $0 | 2,725 (Direct) |
View |
Ownership |
2024-04-02 6:10 pm |
N/A 2030-03-31 |
Aileron Therapeutics Inc. | ALRN | Garner Charles Senior Vice President, Finance |
0 | $0 | 375,347 (Direct) |
View |
2024-03-05 Exercise |
2024-03-06 5:06 pm |
N/A N/A |
AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN President and COO |
2,002 | $0 | 7,347 (Direct) |
View |
2024-02-28 Option Award |
2024-03-01 4:05 pm |
N/A 2034-02-27 |
AILERON THERAPEUTICS INC | ALRN | Ambros Reinhard J. Director |
2,725 | $0 | 2,725 (Direct) |
View |
2024-02-28 Option Award |
2024-03-01 4:05 pm |
N/A 2034-02-27 |
AILERON THERAPEUTICS INC | ALRN | VON RICKENBACH JOSEF H Director |
2,725 | $0 | 2,725 (Direct) |
View |
2023-10-31 Option Award |
2023-11-02 8:55 pm |
N/A 2033-10-30 |
AILERON THERAPEUTICS INC | ALRN | Fairey William Director |
5,450 | $0 | 5,450 (Direct) |
View |
2023-10-31 Option Award |
2023-11-02 8:53 pm |
N/A 2033-10-30 |
AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director |
5,450 | $0 | 5,450 (Direct) |
View |
Ownership |
2023-11-02 8:51 pm |
N/A 2032-05-08 |
AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director |
0 | $0 | 17,064 (Direct) |
View |
Ownership |
2023-11-02 8:50 pm |
N/A 2031-11-16 |
AILERON THERAPEUTICS INC | ALRN | Fairey William Director |
0 | $0 | 17,064 (Direct) |
View |
Ownership |
2023-11-02 8:47 pm |
N/A N/A |
AILERON THERAPEUTICS INC | ALRN | WINDSOR JAMES BRIAN See Remarks |
0 | $0 | 926,834 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:22 pm |
N/A 2032-06-14 |
AILERON THERAPEUTICS INC | ALRN | Morrison Jodie Pope Director |
54,500 | $0 | 54,500 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:18 pm |
N/A 2032-06-14 |
AILERON THERAPEUTICS INC | ALRN | MCKEE WILLIAM Director |
54,500 | $0 | 54,500 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:16 pm |
N/A 2032-06-14 |
AILERON THERAPEUTICS INC | ALRN | VON RICKENBACH JOSEF H Director |
54,500 | $0 | 54,500 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:12 pm |
N/A 2032-06-14 |
AILERON THERAPEUTICS INC | ALRN | Sigal Nolan Howard Director |
54,500 | $0 | 54,500 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:12 pm |
N/A 2032-06-14 |
AILERON THERAPEUTICS INC | ALRN | Ambros Reinhard J. Director |
54,500 | $0 | 54,500 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 5:10 pm |
N/A 2032-06-14 |
AILERON THERAPEUTICS INC | ALRN | Bailey Jeffrey Allen Director |
54,500 | $0 | 54,500 (Direct) |
View |
2022-03-30 Option Award(A) |
2022-03-30 8:33 pm |
N/A 2032-03-29 |
AILERON THERAPEUTICS INC | ALRN | Aivado Manuel See Remarks |
1,133,000 | $0 | 1,133,000 (Direct) |
View |